Skip to main content
. 2016 Feb 11;7(2):e2094. doi: 10.1038/cddis.2016.11

Figure 4.

Figure 4

Structural simulation of ANP by the combined drugs competitively targets phosphorylation of JNK/Erk. (Aa–c) The two-dimensional chemical structural formulas of PL, ZA and ANP. (d and e) The three-dimensional chemical structural formulas of PL, ZA and ANP. (B) Molecular docking of the combination of PL and ZA with JNK-1 or Erk-1 kinases. (C) Optimization of reaction conditions for enzymatic activity of the JNK-1/Erk-1 proteases. (D) HTRF assay of competitiveness of PL and ZA alone against ANP binding to JNK/Erk. (E) HTRF assay of competitiveness of the combined drugs against ANP binding to JNK/Erk. (F) BMMs were cultured with 30 ng/ml MCSF and 50 ng/ml RANKL with or without the combined drugs. The downstream expression of c-Jun/c-Fos/NFATc-1 was investigated via western blotting. The data are presented as the means±S.D. All experiments were repeated at least three times (**significant difference at P<0.05)